Home
About Us
Overview
Culture
Team
Drug R & D
Fields
Indications
Pipeline
Technology Platform
Biotechnology Platform
Chemistry Service
News Center
Company News
Industry News
Join Us
Team Building
Career Development
Contact Us
previous page
BB102, a highly selective and potent reversible-covalent FGFR4 inhibitor induces targeted-protein degradation through lysosomal autophagy
BB5523, a multiple kinase inhibitor with HPK1, VEGFR2 and TNIK inhibition, enhanced antitumor immunity in tumor models
next page
上一页